B 
Beijing Bohui Science & Technology Co 688004.SS · CNY
Information Technology · Shanghai · 🇨🇳 China
39.19
+3.38%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in CNY, from our data supplier.
Revenue
CN¥171.0m
FY2016FY2025
Net income
−CN¥22.7m
FY2016FY2025
Free cash flow
CN¥398,293
FY2016FY2025
Shareholders' equity
CN¥581.9m
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | CN¥171.0m | CN¥172.8m | CN¥191.8m | CN¥157.0m | CN¥287.1m | CN¥287.8m | CN¥274.6m | CN¥283.9m | CN¥195.6m | CN¥149.7m |
| Research and development | CN¥49.0m | CN¥54.2m | CN¥55.0m | CN¥48.2m | CN¥47.8m | CN¥47.3m | CN¥42.2m | CN¥39.9m | CN¥39.3m | CN¥32.0m |
| Operating income | −CN¥22.2m | −CN¥38.8m | −CN¥50.1m | −CN¥38.1m | CN¥50.6m | CN¥49.7m | CN¥54.3m | CN¥60.9m | CN¥34.5m | CN¥11.5m |
| Net income | −CN¥22.7m | −CN¥38.5m | −CN¥43.2m | −CN¥31.1m | CN¥49.2m | CN¥46.4m | CN¥50.9m | CN¥55.0m | CN¥30.7m | CN¥21.4m |
| Diluted earnings per share | -0.29 | -0.46 | -0.54 | -0.40 | 0.63 | 0.57 | 0.82 | 0.71 | 0.75 | 0.55 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | CN¥710.0m | CN¥726.0m | CN¥779.8m | CN¥823.4m | CN¥836.2m | CN¥800.9m | CN¥454.9m | CN¥353.7m | CN¥313.9m | CN¥239.9m |
| Cash and short-term investments | — | CN¥183.8m | CN¥172.4m | CN¥307.1m | CN¥389.8m | CN¥590.0m | CN¥127.2m | CN¥20.1m | CN¥66.2m | CN¥59.8m |
| Total liabilities | CN¥128.2m | CN¥110.7m | CN¥110.1m | CN¥108.6m | CN¥88.0m | CN¥88.2m | CN¥146.2m | CN¥95.9m | CN¥141.0m | CN¥90.7m |
| Debt | CN¥6.7m | CN¥33.1m | CN¥5.5m | CN¥2.8m | CN¥4.0m | CN¥9.5m | CN¥8.1m | — | CN¥7.3m | — |
| Shareholders' equity | CN¥581.9m | CN¥615.3m | CN¥669.7m | CN¥714.7m | CN¥748.1m | CN¥712.7m | CN¥308.8m | CN¥257.8m | CN¥172.9m | CN¥149.2m |
| Shares outstanding | 78m | 83m | 81m | 79m | 78m | 82m | 62m | 78m | 41m | 39m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | CN¥3.0m | CN¥13.0m | −CN¥24.0m | CN¥1.9m | CN¥40.7m | CN¥26.5m | CN¥39.9m | CN¥26.6m | CN¥15.7m | CN¥18.2m |
| Capital spending | −CN¥2.6m | −CN¥9.0m | −CN¥6.2m | −CN¥27.6m | −CN¥219.0m | −CN¥6.2m | −CN¥931,615 | −CN¥2.4m | −CN¥2.1m | −CN¥3.0m |
| Free cash flow | CN¥398,293 | CN¥4.0m | −CN¥30.1m | −CN¥25.7m | −CN¥178.3m | CN¥20.3m | CN¥39.0m | CN¥24.2m | CN¥13.6m | CN¥15.2m |
| Dividends paid | −CN¥1.3m | — | −CN¥96,662 | −CN¥4.9m | −CN¥14.2m | −CN¥14.2m | −CN¥14.2m | −CN¥7.0m | −CN¥7.0m | — |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | CN¥21.8m | CN¥18.4m | CN¥56.1m | CN¥63.7m | CN¥29.3m | CN¥21.9m | CN¥62.6m | CN¥53.7m |
| Operating income | −CN¥15.5m | −CN¥11.1m | −CN¥9.6m | CN¥2.3m | −CN¥11.9m | −CN¥3.4m | −CN¥4.9m | −CN¥12.8m |
| Net income | −CN¥12.9m | −CN¥7.9m | −CN¥8.6m | CN¥2.8m | −CN¥12.5m | −CN¥4.4m | −CN¥3.6m | −CN¥12.6m |
| Diluted earnings per share | -0.17 | -0.10 | -0.11 | 0.04 | -0.16 | -0.06 | -0.04 | -0.15 |
| Cash from operations | — | — | — | −CN¥9.0m | −CN¥11.0m | −CN¥26.0m | CN¥52.0m | −CN¥2.0m |
| Capital spending | — | — | — | −CN¥2.0m | — | — | −CN¥1.0m | — |
| Free cash flow | — | — | — | −CN¥11.0m | — | — | CN¥51.0m | — |
| Total assets | CN¥672.9m | CN¥672.6m | CN¥710.0m | CN¥722.7m | CN¥705.5m | CN¥721.2m | CN¥726.0m | CN¥724.7m |
| Cash and short-term investments | — | — | — | CN¥158.4m | CN¥206.4m | CN¥171.4m | CN¥205.3m | CN¥121.6m |
| Debt | CN¥6.7m | CN¥6.7m | CN¥6.7m | CN¥31.2m | CN¥50.1m | CN¥50.1m | CN¥30.1m | CN¥1.3m |
| Shareholders' equity | CN¥561.1m | CN¥574.0m | CN¥581.9m | CN¥590.1m | CN¥589.0m | CN¥607.6m | CN¥615.3m | CN¥637.1m |
Financial ratios
Data as of 30 Oct 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Operating margin | -13.0% | -22.5% | -26.6% | -22.9% | 18.8% | 17.3% |
| Net margin | -13.3% | -22.3% | -22.5% | -19.8% | 17.1% | 16.1% |
| Return on equity | -3.9% | -6.3% | -6.4% | -4.4% | 6.6% | 6.5% |
| Return on assets | -3.2% | -5.3% | -5.5% | -3.8% | 5.9% | 5.8% |
| Free cash flow yield | 0.2% | 0.7% | -0.6% | 1.0% | 9.0% | 1.1% |
| Revenue growth | -1.1% | -9.9% | 22.2% | -45.3% | -0.2% | 4.8% |
| Earnings growth | -41.0% | -10.9% | 38.7% | -163.3% | 5.9% | -8.8% |
| Current ratio | 3.31x | 3.03x | 3.43x | 4.51x | 7.00x | 8.86x |
| Debt to equity | 0.01x | 0.05x | 0.00x | 0.00x | 0.00x | 0.01x |
| Equity ratio | 82.0% | 84.8% | 85.9% | 86.8% | 89.5% | 89.0% |
| Interest coverage | -14.03x | -85.06x | -160.82x | -167.77x | 193.12x | 308.31x |
| R&D as a share of sales | 28.7% | 31.4% | 28.7% | 30.7% | 16.7% | 16.4% |
| Buybacks as a share of market value | 6.5% | -3.0% | -2.6% | -0.9% | 4.5% | -31.6% |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 2.9% | -9.9% | 5.5% |
| Operating income | -16.5% | — | — |
| Net income | -10.0% | — | — |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Operating margin | -17.7% | -21.5% | -3.9% | 5.1% |
| Net margin | -17.8% | -19.6% | -3.1% | 5.7% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Price to earnings | -79.0 | -32.6 | -38.9 | -37.1 | 39.5 | 58.1 |
| Price to sales | 10.5 | 7.3 | 8.8 | 7.3 | 6.8 | 9.4 |
Dividends and splits
Per share, in the currency the company pays
Paid for 0 years. Last went ex-dividend on 1 Jun 2022.
| FY2022 | FY2021 | |
|---|---|---|
| Paid in the year | 0.062 | 0.177 |
- 1.41-for-1 split · 30 May 2024
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.